Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading SafiledCriticalAres Trading Sa
Publication of TW200503750ApublicationCriticalpatent/TW200503750A/en
Application grantedgrantedCritical
Publication of TWI322692BpublicationCriticalpatent/TWI322692B/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The invention relates to the field of pharmaceutical formulations of follicle-stimulating hormone (FSH), luteinising hormone (LH), and mixtures of FSH and luteinising hormone (LH), and to methods of producing such formulations.
TW93109599A2003-05-272004-04-07Fsh and lh pharmaceutical formulations
TWI322692B
(en)
Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer